Aus­tralian bio­phar­ma buys ra­dioiso­tope pro­duc­er in its next step to ‘dou­ble’ ca­pac­i­ty in 2024 

Telix Phar­ma­ceu­ti­cals is still on its ra­dio­phar­ma man­u­fac­tur­ing shop­ping spree. The Aus­tralian biotech is buy­ing com­mer­cial-stage ra­dioiso­tope pro­duc­er ARTMS for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER